Ceramide Containing Multivesicular Emulsion Application . . .

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)30 enrolled

Overview

We believe that using a ceramide based foot cream two times a day for two weeks will prevent water loss and overall foot dryness in patients with non-insulin dependent diabetes.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Foot Transepidermal Water Loss in Patients in NIDDM Foot Dryness in Patients With NIDDM

Interventions

CeraVeDRUG

Using OTC cream on foot twice daily for two weeks.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \>18 years of age * non insulin-dependent diabetes * moderate to severe xerosis of both feet \[a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)\] * capable of understanding and signing consent form Exclusion Criteria: * history of ichthyosis vulgaris * known hypersensitivity to the topical product used in the study * previous use of high potency steroids (class I and II) in past 2 week * presence of acute skin disease or infection, such as vasculitis or cellulitis * presence of foot ulcer * evidence of gangrene

Outcomes

Primary Outcomes

Decrease transepidermal water loss and foot dryness in study subjects.

Time frame: 5 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.